Electrophoretic mobility of Alzheimer's amyloid-β peptides in urea-sodium dodecyl sulfate-polyacrylamide gel electrophoresis

Analytical Biochemistry

Volumn 323, Issue 1, 2003, Pages 103-113

  Kawooya, John K ^a   Emmons, Thomas L ^b,c   Gonzalez DeWhitt, Patricia A ^b,d   Camp, Melissa C ^a   D'Andrea, Susan C ^a  

^a SANOFI   (France)

^b CEPHALON INC   (United States)

^c PFIZER INC   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; AMINO ACIDS; ELECTROPHORETIC MOBILITY; GLYCOPROTEINS; HYDROPHOBICITY; LANTHANUM COMPOUNDS; METABOLISM; NEURODEGENERATIVE DISEASES; PEPTIDES; SULFUR COMPOUNDS; UREA;

AMYLOID-BETA PEPTIDES; CONDITIONED MEDIUM; HIGH SELECTIVITY; NEGATIVE CHARGE; SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS; SECONDARY STRUCTURES; SODIUM DODECYL SULFATE SOLUTIONS; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS;

SODIUM DODECYL SULFATE;

AMYLOID BETA PROTEIN; DODECYL SULFATE SODIUM; PEPTIDE DERIVATIVE; UREA;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROPHORETIC MOBILITY; HELA CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; UREA SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS;

EID: 0242606391     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.08.027     Document Type: Article

References (53)

1. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
2. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-31.
3. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
4. Masters C.L., Simms G., Weideman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
5. Roher A.E., Lowenson J.D., Clarke S., Cotter R.J., Ball M.J., beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits implications for the pathology of Alzheimer's disease Proc. Natl. Acad. Sci. USA. 90:1993;10836-10840.
6. Roher A.E., Palmer K.C., Yurewicz E.C., Ball M.J., Greenberg B.D. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer's disease brain tissue. J. Neurochem. 61:1993;1916-1926.
7. Roher A.E., Lowenson J.D., Clarke S., Wolkow C., Wang R., Cotter R.J., Reardon I.M., Zürcher-Neely H.A., Heinrikson R.L., Ball M.J., Greenberg B.D. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:1993;3072-3083.
8. Näslund J., Karlström A.R., Tjernberg L.O., Schierhorn A., Terenius L., Nordstedt C. High-resolution separation of amyloid beta-peptides: structural variants present in Alzheimer's disease amyloid. J. Neurochem. 67:1996;294-301.
9. Greenberg B.D., Savage M.J., Howland D.S., Ali S.M., Siedlak S.L., Perry G., Siman R., Scott R.W. APP transgenesis: approaches toward the development of animal models for Alzheimer's disease neuropathology. Neurobiol. Aging. 17:1996;153-171.
10. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashler J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature. 402:1999;533-537.
11. Hussain I., Powell D.J., Howlett D.R., Tew D.G., Meek T.M., Chapman C., Gloger I.S., Murphy K.E., Southan C.D., Ryan D.M., Smith T.S., Simmons D.L., Walsh F.S., Dingwall C., Christie G. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14:1999;419-427.
12. Vassar R., Bennett B.D., Babu-Khan S., Khan S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jeronsinski M.A., Bierre L., Curran E., Burgess T., Louis J.-C., Collins F., Treanor J., Rogers G., Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286:1999;735-741.
13. Sinha S., Anderson J.P., Barabour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomonsaari S.M., Wang S., Walker D., Zhao J., McConlogue L., John V. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 402:1999;537-540.
14. Lin X., Koelsch G., Wu S., Downs D., Dashti A., Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 97:2000;1456-1460.
15. Struhl G., Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 398:1999;522-525.
16. Selkoe D.J., Wolfe M.S. In search of gamma-secretase: presenilin at the cutting edge. Proc. Natl. Acad. Sci. USA. 97:2000;5690-5692.
17. Li Y.M., Lai M.T., Xu M., Huang Q., Dimuzio-Mower J., Sardana M.K., Shi X.P., Yin K.C., Shafer J.A., Gardell S.J. Presenilin 1 is linked with gamma-secretase activity in the detergent-solubilized state. Proc. Natl. Acad. Sci. USA. 97:2000;6138-6143.
18. Honda T., Marotta C.A. Arginine-specific endopeptidases modify the aggregation properties of a synthetic peptide derived from Alzheimer beta/A4 amyloid. Neurochem. Res. 17:1992;367-374.
19. Hilbich C., Kristers-Wolkie B., Reed J., Masters C.L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J. Mol. Biol. 218:1991;149-163.
20. Sweeny P.J., Darker J.G., Neville W.A., Humphries J., Camilleri P. Electrophoretic techniques for the analysis of synthetic amyloid beta-A4-related peptides. Anal. Biochem. 212:1993;179-184.
21. Soreghan B., Kosmoski J., Glabe C. Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269:1994;28551-28554.
22. 42 in cerebrovascular deposits Amyloid: Int. J. Exp. Clin. Invest. 2:1995;234-240.
23. Klafki H.-W., Wiltfang J., Staufenbiel M. Electrophoretic separation of betaA4 peptides (1-40) and (1-42). Anal. Biochem. 237:1996;24-29.
24. Klafki H.-W., Abramowski D., Swoboda R., Paganetti P.A., Staufenbiel M. The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities. J. Biol. Chem. 271:1996;28655-28659.
25. Wiltifang J., Smirnov A., Schnierstein B., Keleman G., Matthies U., Klafki H.W., Staufenbiel M., Huther G., Ruther E., Kornhuber J. Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis. 18:1997;527-532.
26. Huang J., Matthews H.R. Application of sodium dodecyl sulfate-gel electrophoresis to low molecular weight polypeptides. Anal. Biochem. 188:1990;114-117.
27. Weber K., Osborne M. The reliability of molecular weight determination by sodium dodecyl sulfate polyacrylamide gel electrophoresis. J. Biol. Chem. 244:1972;4406-4412.
28. Wiltfang J., Esslemann H., Cupers P., Neumann M., Kretzschmar H., Beyermann M., Schleuder D., Jahn H., Rüther E., Kornhuber J., Annaert W., De Strooper B., Saftig P. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. J. Biol. Chem. 276:2001;42645-42657.
29. Huse J.T., Liu K., Pijak D.S., Carlin D., Lee M.-Y.V., Doms R.W. Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J. Biol. Chem. 277:2002;16284-16378.
30. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietzik, Findlay K.A., Smith T., Murphy M.P., Bulter T., Knag D.E., Marquez-Sterling N., Golde T.E., Koo E. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 414:2001;212-216.
31. Schägger H., Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
32. Provencher S.W., Glockner J. Estimation of globular protein secondary structure from circular dichroism. Biochemistry. 20:1981;33-37.
33. Greenfield N.J. Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. Anal. Biochem. 235:1996;1-10.
34. Hummel J.P., Dryer W.J. Measurement of protein-binding phenomenon by gel filtration. Biochim. Biophys. Acta. 63:1962;530-532.
35. Beeckmans S. Chromatographic methods to study protein-protein interactions. Methods. 19:1999;278-305.
36. Kuentzel S.L., Gonzalez-DeWhitt P.A., Lowery D.E., Altman R.A., Leone J.W., Heinrikson R.L., Greenberg B.D., Raub T.J. Overexpression of COOH-terminal fragment of β-amyloid precursor protein in HeLa cells results in accumulation in a pre-Golgi compartment and generation of an Aβ-like fragment. Amyloid: Int. J. Exp. Clin. Invest. 3:1996;86-99.
37. Akerstrom B., Bjorck L. A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties. J. Biol. Chem. 261:1986;10240-10247.
38. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
39. Fezoui Y., Teplow D.B. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. J. Biol. Chem. 277:2002;36948-36954.
40. Glenner G.G. The bases of the staining of amyloid fibers: their physico-chemical nature and the mechanism of their dye-substrate interaction. Prog. Histochem. Cytochem. 13:1981;1-37.
41. Kirschner D.A., Abraham C., Selkoe D.J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc. Natl. Acad. Sci. USA. 83:1986;503-507.
42. Dovey H.F., Suomensaari-Chrysler S., Lieberburg I., Sinha S., Keim P.S. Cells with a familial Alzheimer's disease mutation produce authentic beta-peptide. NeuroReport. 4:1993;1039-1042.
43. Podlisny M.B., Ostaszewski B.L., Squazzo S.L., Koo E.H., Rydell R.E., Teplow D.B., Selkoe D. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270:1995;9564-9570.
44. Suzuki N., Cheung T.T., Cai X.-D., Odaka A., Otvos L., Eckman C., Golde T.E., Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
45. Gordon J.A., Jencks W.P. The relationship of structure to the effectiveness of denaturing agents for proteins. Biochemistry. 2:1963;47-57.
46. Lenard J. Rapid and effective removal of sodium dodecyl sulfate from proteins. Biochem. Biophys. Res. Commun. 45:1971;662-668.
47. Takagi T., Kubo K. Sodium dodecyl sulfate-protein polypeptide complexes in 8. M urea with special reference to sodium dodecyl sulfate-polyacrylamide gel electrophoresis Biochim. Biophys. Acta. 578:1979;68-75.
48. Anderson B.L., Berry R.W., Telser A. A sodium dodecyl sulfate-polyacrylamide gel electrophoresis system that separates peptides and proteins in the molecular weight range of 2500 to 90,000. Anal. Biochem. 132:1983;365-375.
49. Eisenberg D. Three dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53:1984;595-623.
50. Lundahl P., Greijer E., Sandberg M., Cardell S., Eriksson K.-O. A model for ionic and hydrophobic interactions and hydrogen-bonding in sodium dodecyl sulfate-protein complexes. Biochim. Biophys. Acta. 873:1986;20-26.
51. Marcinowski K.J., Shao H., Clancy E.L., Zagorski M.G. Solution model of residues 1-28 of the amyloid β-peptide when bound to micelles. J. Am. Chem. Soc. 120:1998;11082-11091.
52. a measurements of the β-peptide and mechanism pH-induced amyloid formation. J. Am. Chem. Soc. 121:1999;8698-8706.
53. Jarret J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.